ALBT Avalon GloboCare Corporation

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

	FORM 12b-25	SEC FILE NUMBER 001-38728
		CUSIP NUMBER
	NOTIFICATION OF LATE FILING	05344R203

 

(Check one):	☐ Form 10-K	☐ Form 20-F	☐ Form 11-K
	☒ Form 10-Q	☐ Form 10-D	☐ Form N-CEN		☐ Form N-CSR

 

For Period Ended: March 31, 2024

☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q

For the Transition Period Ended:__________________

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I - REGISTRANT INFORMATION

 

Avalon GloboCare Corp.

Full Name of Registrant

N/A

Former Name if Applicable

4400 Route 9 South, Suite 3100

Address of Principal Executive Office (Street and Number)

Freehold, NJ 07728

City, State and Zip Code

 

 

PART II - RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III - NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

Avalon GloboCare Corp., a Delaware corporation (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 by the prescribed due date without unreasonable effort or expense because of the circumstances described below.

 

Additional time is needed because the financial statements could not be completed in sufficient time to solicit and obtain the necessary review and approval of the Quarterly Report on Form 10-Q, in a timely fashion prior to the prescribed due date. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 will be filed on or before the 5th calendar day following the prescribed due date.

 

PART IV - OTHER INFORMATION

 

(1)	Name and telephone number of person to contact in regard to this notification
	Luisa Ingargiola		(732)		780-4400
	(Name)		(Area Code)		(Telephone Number)
(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
	Yes ☒ NO ☐

 

(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	Yes ☐ NO ☒
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

Avalon GloboCare Corp.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:	May 15, 2024		By:	/s/ Luisa Ingargiola
				Luisa Ingargiola Chief Financial Officer

 

 

3

 

 

---